Price Target. $ (% upside). Analyst Consensus: Strong Buy. Created with Highcharts Strong Sell Sell Hold Buy Strong Buy 0 2 4 6. Stock. Find the latest analyst research, reports, and ratings for Catalyst Pharmaceuticals, Inc. Common Stock (CPRX) at merimax.ru Is Catalyst Pharmaceutical Partners stock a Buy, Sell or Hold? Catalyst Pharmaceutical Partners stock has received a consensus rating of buy. The average. So Catalyst Pharmaceuticals, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes. Bid Price and Ask Price. The bid & ask refers to the price that an investor is willing to buy or sell a stock. The bid is the highest amount that a buyer is.
See the latest Catalyst Pharmaceuticals Inc stock price (CPRX:XNAS), related news, valuation, dividends and more to help you make your investing decisions. Average Recommendation, Buy. Average Target Price, Number Of Ratings, 7. FY Report Date, 12/ Last Quarter's Earnings, We conclude that the current level may hold a buying opportunity as there is a fair chance for Catalyst Pharmaceuticals stock to perform well in the short-term. Catalyst Pharmaceuticals Inc CPRX:NASDAQ. Last Price, Today's Change, Today's Schwab Equity Ratings and the general buy/sell/hold guidance are not. Analyst Ratings. The average analyst rating for CPRX stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to. Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CPRX is experiencing. Catalyst Pharmaceutical currently has an average brokerage recommendation (ABR) of on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on. Stock analysis for Catalyst Pharmaceuticals Inc (CPRX:NASDAQ CM) including stock price Do Not Sell or Share My Personal Information TrademarksPrivacy Policy. Track Catalyst Pharmaceuticals Inc (CPRX) Stock Price, Quote, latest community messages, chart, news and other stock related information Do Not Sell or Share. The Fool has written over articles on Catalyst Pharmaceuticals. Featured Article. 2 Incredible Growth Stocks to Buy Hand Over Fist Right Now. These two. View the real-time CPRX price chart on Robinhood and decide if you want to buy or sell commission-free. Other fees such as trading (non-commission) fees.
Wall Street Analysts See a % Upside in Catalyst (CPRX): Can the Stock Really Move This High? Zacks Investment Research • 08/15/ Find the latest Catalyst Pharmaceuticals, Inc. (CPRX) stock quote Sell. Analyst Price Targets. Average. Current. High. View. CPRX | Complete Catalyst Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Catalyst Pharmaceuticals Stock Buy Hold or Sell Recommendation Stocks. USA. Given the investment horizon of 90 days and your way above-average risk. View Catalyst Pharmaceuticals, Inc. CPRX stock quote prices, financial information, real-time forecasts, and company news from CNN. Current. Buy. 5. 7. Overweight. 0. 0. Hold. 0. 0. Underweight. 0. 0. Sell. 0. 0. ConsensusBuyBuy. Stock Price Target. High, $ Low, $ Average, $ According to analysts, CPRX price target is USD with a max estimate of USD and a min estimate of USD. Check if this forecast comes true in a. Catalyst Pharmaceuticals has received a consensus rating of Buy. The company's average rating score is , and is based on 6 buy ratings, no hold ratings. Assess the Catalyst Pharmaceuticals stock price estimates. View analyst opinion as to whether the stock is a strong buy, strong sell or hold, based on analyst.
Shares Out (Mil): Market Cap: 2, Forward P/E: Dividend Yield: Key Statistics. mean rating - 7 analysts. Sell. Hold. Buy. P/E. Out of 6 analysts, 4 (%) are recommending CPRX as a Strong Buy, 2 (%) are recommending CPRX as a Buy, 0 (0%) are recommending CPRX as a Hold, 0 (0%). Catalyst Pharma Stock Smart Score ; Analyst Consensus. Strong Buy. Average Price Target: $ (% Upside) ; Blogger Sentiment. Bullish. CPRX Sentiment %. 6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Catalyst Pharmaceuticals in the last twelve months. There are currently 6 buy. Based on the Catalyst Pharmaceuticals stock forecast, it's now a good time to buy CPRX stock because it's trading % below our forecast, and it could be.
Fair Value. Research Analysis. Earnings Per Share. + Estimate. Analyst Recommendations. Strong Buy. Buy. Hold. Underperform. Sell. Analyst Price Targets. 0. 0. 0. Hold. 0. 0. 0. Underweight. 0. 0. 0. Sell. 0. 0. 0. Consensus. Buy. -. Buy. Stock Price Target CPRX. High, $ Median, $ Low, $ Average. Overall, Catalyst Pharmaceuticals Inc stock has a Growth Grade of B, Momentum Grade of A Earnings Estimate Revisions Grade of C. Whether or not you should buy.